117 related articles for article (PubMed ID: 28493710)
1. Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors.
Anajafi T; Yu J; Sedigh A; Haldar MK; Muhonen WW; Oberlander S; Wasness H; Froberg J; Molla MS; Katti KS; Choi Y; Shabb JB; Srivastava DK; Mallik S
Mol Pharm; 2017 Jun; 14(6):1916-1928. PubMed ID: 28493710
[TBL] [Abstract][Full Text] [Related]
2. Acridine Orange Conjugated Polymersomes for Simultaneous Nuclear Delivery of Gemcitabine and Doxorubicin to Pancreatic Cancer Cells.
Anajafi T; Scott MD; You S; Yang X; Choi Y; Qian SY; Mallik S
Bioconjug Chem; 2016 Mar; 27(3):762-71. PubMed ID: 26848507
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Responsive, Polymeric Nanocarriers for Targeted Drug Delivery to Estrogen Receptor-Positive Breast Cancer Cell Spheroids.
Mamnoon B; Feng L; Froberg J; Choi Y; Sathish V; Mallik S
Mol Pharm; 2020 Nov; 17(11):4312-4322. PubMed ID: 32926627
[TBL] [Abstract][Full Text] [Related]
4. Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Stemness Inhibitor to Pancreatic Cancer Cells.
Karandish F; Mamnoon B; Feng L; Haldar MK; Xia L; Gange KN; You S; Choi Y; Sarkar K; Mallik S
Biomacromolecules; 2018 Oct; 19(10):4122-4132. PubMed ID: 30169024
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells.
Nahire R; Haldar MK; Paul S; Ambre AH; Meghnani V; Layek B; Katti KS; Gange KN; Singh J; Sarkar K; Mallik S
Biomaterials; 2014 Aug; 35(24):6482-97. PubMed ID: 24797878
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
8. Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.
Karandish F; Froberg J; Borowicz P; Wilkinson JC; Choi Y; Mallik S
Colloids Surf B Biointerfaces; 2018 Mar; 163():225-235. PubMed ID: 29304437
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinase-sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model.
Nagel G; Sousa-Herves A; Wedepohl S; Calderón M
Theranostics; 2020; 10(1):91-108. PubMed ID: 31903108
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG-PCLNanoparticles.
Danafar H; Rostamizadeh K; Davaran S; Hamidi M
Drug Dev Ind Pharm; 2017 Nov; 43(11):1908-1918. PubMed ID: 28737462
[TBL] [Abstract][Full Text] [Related]
11. Facile synthesis of pH-responsive polymersomes based on lipidized PEG for intracellular co-delivery of curcumin and methotrexate.
Curcio M; Mauro L; Naimo GD; Amantea D; Cirillo G; Tavano L; Casaburi I; Nicoletta FP; Alvarez-Lorenzo C; Iemma F
Colloids Surf B Biointerfaces; 2018 Jul; 167():568-576. PubMed ID: 29738983
[TBL] [Abstract][Full Text] [Related]
12. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
Baghbani F; Moztarzadeh F
Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
[TBL] [Abstract][Full Text] [Related]
13. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
14. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y
Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617
[TBL] [Abstract][Full Text] [Related]
15. Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.
Colley HE; Hearnden V; Avila-Olias M; Cecchin D; Canton I; Madsen J; MacNeil S; Warren N; Hu K; McKeating JA; Armes SP; Murdoch C; Thornhill MH; Battaglia G
Mol Pharm; 2014 Apr; 11(4):1176-88. PubMed ID: 24533501
[TBL] [Abstract][Full Text] [Related]
16. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
17. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
18. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
Carlson LJ; Cote B; Alani AW; Rao DA
J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
Misra R; Sahoo SK
Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
[TBL] [Abstract][Full Text] [Related]
20. Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy.
Yoo J; Sanoj Rejinold N; Lee D; Jon S; Kim YC
J Control Release; 2017 Oct; 264():89-101. PubMed ID: 28842316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
